Robeco Institutional Asset Management B.V. Has $130.12 Million Stake in The Clorox Company $CLX

Key Points

• Robeco Institutional Asset Management B.V. significantly increased its stake in The Clorox Company by 101.8%, now owning approximately $130.12 million worth of shares.
• Clorox COO Eric H. Reynolds sold 15,041 shares at an average price of $123.78, reducing his ownership by 21.72% to 54,221 shares.
• The company announced a quarterly dividend of $1.24 per share, with an annualized dividend yield of 4.0%, to be paid on November 6th.

Robeco Institutional Asset Management B.V. grew its position in The Clorox Company (NYSE:CLX - Free Report) by 101.8% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 1,083,723 shares of the company's stock after purchasing an additional 546,761 shares during the quarter. Robeco Institutional Asset Management B.V. owned about 0.88% of Clorox worth $130,123,000 as of its most recent SEC filing.

Other large investors have also added to or reduced their stakes in the company. American National Bank & Trust increased its stake in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company's stock worth $26,000 after acquiring an additional 89 shares during the period. Ransom Advisory Ltd bought a new position in Clorox during the 1st quarter worth $35,000. GW&K Investment Management LLC increased its stake in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company's stock worth $43,000 after acquiring an additional 208 shares during the period. Roble Belko & Company Inc increased its stake in Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company's stock worth $53,000 after acquiring an additional 211 shares during the period. Finally, IMA Advisory Services Inc. bought a new position in Clorox during the 1st quarter worth $58,000. Institutional investors and hedge funds own 78.53% of the company's stock.

Insider Buying and Selling at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of the company's stock in a transaction that occurred on Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This represents a 21.72% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Company insiders own 0.57% of the company's stock.

Clorox Trading Down 0.5%

Shares of CLX stock opened at $122.64 on Thursday. The company has a debt-to-equity ratio of 5.15, a quick ratio of 0.57 and a current ratio of 0.84. The Clorox Company has a 52-week low of $116.53 and a 52-week high of $171.37. The company has a market capitalization of $15.00 billion, a PE ratio of 18.81, a price-to-earnings-growth ratio of 0.99 and a beta of 0.52. The business's fifty day moving average is $123.15 and its 200 day moving average is $129.96.

Clorox (NYSE:CLX - Get Free Report) last posted its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.24 by $0.63. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The firm had revenue of $1.99 billion during the quarter, compared to analysts' expectations of $1.94 billion. During the same period in the prior year, the business earned $1.82 EPS. The company's revenue for the quarter was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be issued a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.0%. Clorox's dividend payout ratio is 76.07%.

Wall Street Analyst Weigh In

CLX has been the topic of a number of research analyst reports. JPMorgan Chase & Co. raised their target price on Clorox from $133.00 to $135.00 and gave the company a "neutral" rating in a report on Monday, September 8th. The Goldman Sachs Group cut their price objective on Clorox from $115.00 to $110.00 and set a "sell" rating on the stock in a report on Wednesday. Barclays cut their price objective on Clorox from $118.00 to $112.00 and set an "underweight" rating on the stock in a report on Tuesday. Zacks Research raised Clorox from a "strong sell" rating to a "hold" rating in a report on Monday. Finally, Wells Fargo & Company lowered their target price on Clorox from $130.00 to $125.00 and set an "equal weight" rating for the company in a research report on Thursday, September 25th. One equities research analyst has rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to data from MarketBeat.com, Clorox has an average rating of "Reduce" and a consensus target price of $134.08.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.